Found 1775 matching trials
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation PHASE2 The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Show More Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Learn More & Join Trial
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) PHASE3 Neutropenia, a condition characterized by an abnormally low number of infec...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Lund University Hospital
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma EARLY_PHASE1 The purpose of this study is to determine if the combination of G-CSF and b...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma PHASE1 Monoclonal antibodies can locate tumor cells and either kill them or delive...
Show More Location
Children's Oncology Group
Learn More & Join Trial
A Study of LY2523355 in Participants With Breast Cancer PHASE2 The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma PHASE2 The purpose of this study is to test see the combined effects of the study ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial